Correlation Between Accelerate Diagnostics and Cannabix Technologies

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Accelerate Diagnostics and Cannabix Technologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Accelerate Diagnostics and Cannabix Technologies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Accelerate Diagnostics and Cannabix Technologies, you can compare the effects of market volatilities on Accelerate Diagnostics and Cannabix Technologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Accelerate Diagnostics with a short position of Cannabix Technologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Accelerate Diagnostics and Cannabix Technologies.

Diversification Opportunities for Accelerate Diagnostics and Cannabix Technologies

-0.18
  Correlation Coefficient

Good diversification

The 3 months correlation between Accelerate and Cannabix is -0.18. Overlapping area represents the amount of risk that can be diversified away by holding Accelerate Diagnostics and Cannabix Technologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cannabix Technologies and Accelerate Diagnostics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Accelerate Diagnostics are associated (or correlated) with Cannabix Technologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cannabix Technologies has no effect on the direction of Accelerate Diagnostics i.e., Accelerate Diagnostics and Cannabix Technologies go up and down completely randomly.

Pair Corralation between Accelerate Diagnostics and Cannabix Technologies

Given the investment horizon of 90 days Accelerate Diagnostics is expected to under-perform the Cannabix Technologies. But the stock apears to be less risky and, when comparing its historical volatility, Accelerate Diagnostics is 1.03 times less risky than Cannabix Technologies. The stock trades about -0.02 of its potential returns per unit of risk. The Cannabix Technologies is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest  38.00  in Cannabix Technologies on August 28, 2024 and sell it today you would lose (11.00) from holding Cannabix Technologies or give up 28.95% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Accelerate Diagnostics  vs.  Cannabix Technologies

 Performance 
       Timeline  
Accelerate Diagnostics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Accelerate Diagnostics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's fundamental indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.
Cannabix Technologies 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Cannabix Technologies has generated negative risk-adjusted returns adding no value to investors with long positions. Despite abnormal performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Accelerate Diagnostics and Cannabix Technologies Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Accelerate Diagnostics and Cannabix Technologies

The main advantage of trading using opposite Accelerate Diagnostics and Cannabix Technologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Accelerate Diagnostics position performs unexpectedly, Cannabix Technologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cannabix Technologies will offset losses from the drop in Cannabix Technologies' long position.
The idea behind Accelerate Diagnostics and Cannabix Technologies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.

Other Complementary Tools

Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Global Correlations
Find global opportunities by holding instruments from different markets